CTA
CMD

Carillon Tower Advisers’s Cantel Medical Corporation CMD Stock Holding History

Carillon Tower Advisers’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$23.3M Buy
295,116
+235,550
+395% +$13.8M 0.14% 213
2020
Q3 		$2.62M Buy
59,566
+10,826
+22% +$533K 0.03% 396
2020
Q2 		$2.16M Buy
48,740
+21,200
+77% +$791K 0.02% 438
2020
Q1 		$989K Sell
27,540
-2,100
-7% -$119K 0.01% 433
2019
Q4 		$2.1M Buy
+29,640
New +$2.15M 0.01% 456

Other funds holding CMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $962M AUM 35.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
DM
Diker Management New York $130M AUM 97.77% 1-Year Est. Return

Carillon Tower Advisers's CMD Position: Q4 2020 in Review

Carillon Tower Advisers increased its Cantel Medical Corporation (CMD) stake by 395% in Q4 2020, buying an estimated $13.8M and bringing the position to 295,116 shares worth $23.3M. The position accounts for 0.14% of the portfolio, ranked #213.

Carillon Tower Advisers first reported a position in CMD in Q4 2019 and has held it in 5 quarters since. 230 funds tracked by Wall St. Rank hold CMD as of Q4 2020.

  • Carillon Tower Advisers held 295,116 shares of Cantel Medical Corporation worth $23.3M as of Q4 2020.
  • Carillon Tower Advisers bought 235,550 Cantel Medical Corporation shares in Q4 2020, an estimated $13.8M.
  • Cantel Medical Corporation made up 0.14% of Carillon Tower Advisers's portfolio in Q4 2020, its #213 holding.
  • Carillon Tower Advisers first reported a position in Cantel Medical Corporation in Q4 2019 and has held it in 5 quarters since.
  • 230 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.